Pair Matcher (PaM): fast model-based optimization of treatment/case-control matches

Area of Science:

• Genetics
• Clinical Trials
• Bioinformatics

Background:

• Clinical trials match participants by demographics for drug efficacy studies.
• Population stratification bias due to uneven ancestry distribution in groups causes irreproducibility.
• Existing methods like principal component analysis (PCA) may not fully address this bias.

Purpose of the Study:

• To introduce Pair Matcher (PaM), a novel tool to mitigate stratification bias in clinical trials.
• To enhance the accuracy and reproducibility of trial results through optimized participant pairing.
• To enable precision medicine by characterizing treatment responders based on ancestry.

Main Methods:

• PaM optimizes participant pairing using both genetic and demographic criteria.
• Assignments can be optimized before (a priori) or after (a posteriori) trial commencement.
• The method was validated using simulated and real-world datasets.

Main Results:

• PaM identifies more genetically homogeneous pairs compared to competing methods, including PCA.
• Optimized pairing leads to more homogeneous treatment and control groups.
• Ancestral inferences from PaM facilitate responder characterization.

Conclusions:

• PaM effectively reduces stratification bias in clinical trials.
• The tool enhances the reliability and reproducibility of research findings.
• PaM supports the development of precision medicine strategies.